BR112013014021A8 - Métodos para tratamento de calvície e promoção de crescimento de cabelos - Google Patents

Métodos para tratamento de calvície e promoção de crescimento de cabelos

Info

Publication number
BR112013014021A8
BR112013014021A8 BR112013014021A BR112013014021A BR112013014021A8 BR 112013014021 A8 BR112013014021 A8 BR 112013014021A8 BR 112013014021 A BR112013014021 A BR 112013014021A BR 112013014021 A BR112013014021 A BR 112013014021A BR 112013014021 A8 BR112013014021 A8 BR 112013014021A8
Authority
BR
Brazil
Prior art keywords
hair growth
methods
baldness
integumental
promotion
Prior art date
Application number
BR112013014021A
Other languages
English (en)
Other versions
BR112013014021A2 (pt
Inventor
P Barman Shikha
d ju William
C Kellogg Scott
M Prouty Stephen
Schweiger Eric
Lederman Seth
Osbakken Mary
D Schinazi Alan
Original Assignee
Follica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Follica Inc filed Critical Follica Inc
Publication of BR112013014021A2 publication Critical patent/BR112013014021A2/pt
Publication of BR112013014021A8 publication Critical patent/BR112013014021A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491—Surgical glue applicators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/54—Chiropodists' instruments, e.g. pedicure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H7/00—Devices for suction-kneading massage; Devices for massaging the skin by rubbing or brushing not otherwise provided for
    • A61H7/002—Devices for suction-kneading massage; Devices for massaging the skin by rubbing or brushing not otherwise provided for by rubbing or brushing
    • A61H7/004—Devices for suction-kneading massage; Devices for massaging the skin by rubbing or brushing not otherwise provided for by rubbing or brushing power-driven, e.g. electrical
    • A61H7/005—Devices for suction-kneading massage; Devices for massaging the skin by rubbing or brushing not otherwise provided for by rubbing or brushing power-driven, e.g. electrical hand-held
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/0616—Skin treatment other than tanning
    • A61N5/0617—Hair treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/067—Radiation therapy using light using laser light
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A45—HAND OR TRAVELLING ARTICLES
    • A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
    • A45D2200/00—Details not otherwise provided for in A45D
    • A45D2200/10—Details of applicators
    • A45D2200/1054—Abrasive cosmetic skin peeling or scrubbing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00367—Details of actuation of instruments, e.g. relations between pushing buttons, or the like, and activation of the tool, working tip, or the like
    • A61B2017/00398—Details of actuation of instruments, e.g. relations between pushing buttons, or the like, and activation of the tool, working tip, or the like using powered actuators, e.g. stepper motors, solenoids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00491—Surgical glue applicators
    • A61B2017/00495—Surgical glue applicators for two-component glue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00681—Aspects not otherwise provided for
    • A61B2017/00734—Aspects not otherwise provided for battery operated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00747—Dermatology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00747—Dermatology
    • A61B2017/00761—Removing layer of skin tissue, e.g. wrinkles, scars or cancerous tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B2017/320004—Surgical cutting instruments abrasive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452—Skin
    • A61B2018/00476—Hair follicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577—Ablation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/10—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy
    • A61H2201/105—Characteristics of apparatus not provided for in the preceding codes with further special therapeutic means, e.g. electrotherapy, magneto therapy or radiation therapy, chromo therapy, infrared or ultraviolet therapy with means for delivering media, e.g. drugs or cosmetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/12—Driving means
    • A61H2201/1207—Driving means with electric or magnetic drive
    • A61H2201/1215—Rotary drive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16—Physical interface with patient
    • A61H2201/1602—Physical interface with patient kind of interface, e.g. head rest, knee support or lumbar support
    • A61H2201/1604—Head
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2201/00—Characteristics of apparatus not provided for in the preceding codes
    • A61H2201/16—Physical interface with patient
    • A61H2201/1657—Movement of interface, i.e. force application means
    • A61H2201/1671—Movement of interface, i.e. force application means rotational
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H2205/00—Devices for specific parts of the body
    • A61H2205/02—Head
    • A61H2205/021—Scalp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H23/00—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms
    • A61H23/02—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive
    • A61H23/0245—Percussion or vibration massage, e.g. using supersonic vibration; Suction-vibration massage; Massage with moving diaphragms with electric or magnetic drive with ultrasonic transducers, e.g. piezoelectric
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits
    • A61K2800/884—Sequential application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0644—Handheld applicators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Electromagnetism (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Rehabilitation Therapy (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

MÉTODOS PARA TRATAMENTO DE CALVÍCIE E PROMOÇÃO DE CRESCIMENTO DE CABELOS. A invenção refere-se a métodos de tratamento de calvície, tratamento de alopecia, promoção de crescimento capilar e/ou promoção de desenvolvimento de folículo capilar e/ou ativação ou estimulação em uma área da pele de um indivíduo (por exemplo, um humano) através da submissão da dita área da pela à perturbação integumental. A perturbação integumental pode ser usada em combinação com outros tratamentos para promover o crescimento capilar. A invenção fornece dispositivos para perturbação integumental para promover crescimento capilar, e fornece composições farmacêuticas para uso em combinação com perturbação integumental para promover o crescimento capilar.
BR112013014021A 2010-12-06 2011-12-06 Métodos para tratamento de calvície e promoção de crescimento de cabelos BR112013014021A8 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US42028210P 2010-12-06 2010-12-06
US201161453902P 2011-03-17 2011-03-17
US201161453919P 2011-03-17 2011-03-17
US201161478689P 2011-04-25 2011-04-25
US201161513906P 2011-08-01 2011-08-01
PCT/US2011/063557 WO2012078649A1 (en) 2010-12-06 2011-12-06 Methods for treating baldness and promoting hair growth

Publications (2)

Publication Number Publication Date
BR112013014021A2 BR112013014021A2 (pt) 2016-07-12
BR112013014021A8 true BR112013014021A8 (pt) 2017-10-03

Family

ID=46207483

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013014021A BR112013014021A8 (pt) 2010-12-06 2011-12-06 Métodos para tratamento de calvície e promoção de crescimento de cabelos

Country Status (8)

Country Link
US (3) US20140079686A1 (pt)
EP (2) EP2648676A4 (pt)
JP (4) JP2014500275A (pt)
AU (3) AU2011338530B2 (pt)
BR (1) BR112013014021A8 (pt)
CA (1) CA2819859A1 (pt)
IL (2) IL226699A (pt)
WO (1) WO2012078649A1 (pt)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8048089B2 (en) 2005-12-30 2011-11-01 Edge Systems Corporation Apparatus and methods for treating the skin
US9566088B2 (en) 2006-03-29 2017-02-14 Edge Systems Llc Devices, systems and methods for treating the skin
WO2014151104A1 (en) 2013-03-15 2014-09-25 Edge Systems Llc Devices, systems and methods for treating the skin
DK2037967T3 (en) 2006-06-16 2017-03-13 Univ Pennsylvania PROSTAGLANDIN-D2 RECEPTOR ANTAGONISTS FOR TREATMENT OF ANDROGENETIC ALOPECI
ITMI20071616A1 (it) 2007-08-03 2009-02-04 Cosmo Spa Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
WO2009088884A1 (en) 2008-01-04 2009-07-16 Edge Systems Corporation Apparatus and method for treating the skin
JP2014500275A (ja) * 2010-12-06 2014-01-09 フォリカ，インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
CA2831582C (en) 2011-03-28 2019-01-08 Mei Pharma, Inc. (alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
JP6193968B2 (ja) * 2012-03-21 2017-09-06 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 発毛を調節するための組成物および方法
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20140023618A1 (en) * 2012-07-23 2014-01-23 Applied Biology Systems and methods for treatment of androgenetic skin conditions by microbial organisms
NL2009971C2 (en) * 2012-12-12 2014-06-16 Hair Science Inst Method for in vivo hair multiplication.
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
AU2014209141B2 (en) 2013-01-24 2018-05-10 Palvella Therapeutics, Inc. Compositions for transdermal delivery of mTOR inhibitors
US9855211B2 (en) * 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US9861442B2 (en) * 2013-03-15 2018-01-09 Nikolai Tankovich Laser filler
US20140276359A1 (en) * 2013-03-15 2014-09-18 Plum Systems Co. Apparatus and method for tissue rejuvenation
AU2014259787B2 (en) * 2013-05-03 2018-03-08 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Skin substitutes and methods for hair follicle neogenesis
WO2014197685A1 (en) * 2013-06-05 2014-12-11 The Regents Of The University Of California Hydrogel pressure sealant system
US10413359B2 (en) 2013-07-18 2019-09-17 International Business Machines Corporation Laser-assisted transdermal delivery of nanoparticulates and hydrogels
CN105658221B (zh) * 2013-09-26 2022-05-10 高德美国际公司 用于治疗萎缩性皮肤瘢痕形成的前列腺素F2α及其类似物
WO2015106172A1 (en) * 2014-01-10 2015-07-16 Sebacia, Inc. Treatment intervals for use of compositions comprising energy absorbing materials for dermatological applications
TW201538729A (zh) * 2014-02-12 2015-10-16 Replicel Life Sciences Inc 與口腔治療有關之組合物及方法
US10500233B2 (en) 2014-02-12 2019-12-10 Replicel Life Sciences Inc. Compositions and methods for treating bone, joints and cartilage
KR20170023776A (ko) * 2014-02-26 2017-03-06 루마 세러퓨틱스 인코포레이티드 자외선 광선 치료 장치들 및 방법들
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US11696883B2 (en) 2014-05-23 2023-07-11 Triple Hair Inc. Compositions for reducing hair loss and/or increasing hair regrowth
CA2903734C (en) 2014-05-23 2016-03-01 Houfar SEKHAVAT Compositions for reducing hair loss and/or increasing hair regrowth
US10987284B2 (en) 2014-07-14 2021-04-27 Michael V. Greene Volume boosting molding hair coloring creme formulation
WO2016010988A1 (en) * 2014-07-14 2016-01-21 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
KR20170040209A (ko) 2014-07-29 2017-04-12 쎄러퓨틱스엠디, 인코퍼레이티드 경피 크림
US20160030728A1 (en) * 2014-07-31 2016-02-04 Tekni-Plex, Inc. Extrudable tubing and solvent bonded fitting for delivery of medicinal fluids
JP2016088933A (ja) * 2014-11-01 2016-05-23 育宏 南 ＡＧＥｓ産生抑制剤およびその用途
TWI548413B (zh) * 2014-11-07 2016-09-11 國立臺灣大學 誘導毛囊新生的皮膚萃取物、組合物及其用途
EP4324414A3 (en) 2014-12-23 2024-05-01 HydraFacial LLC Devices and methods for treating the skin using a rollerball or a wicking member
US10179229B2 (en) 2014-12-23 2019-01-15 Edge Systems Llc Devices and methods for treating the skin using a porous member
KR101832121B1 (ko) * 2014-12-31 2018-02-26 (주)휴온스 Rgd 모티프 함유 펩티드 또는 이의 단편을 포함하는 화상 및 녹내장 치료, 피부 주름 개선 및 발모 촉진용 조성물
US9173921B1 (en) * 2015-03-23 2015-11-03 Jaehyun Lim Method of promoting hair growth by administration of bFGF
KR20160121122A (ko) * 2015-04-10 2016-10-19 차의과학대학교 산학협력단 탈모방지 또는 발모촉진용 조성물
US10628657B2 (en) 2015-06-15 2020-04-21 Nec Corporation Dermal image information processing device, dermal image information processing method, and program
EP3108879A1 (en) 2015-06-25 2016-12-28 Cassiopea S.p.A. High concentration formulation
CN107920948A (zh) * 2015-07-08 2018-04-17 边缘系统有限公司 用于促进毛发生长的装置、系统和方法
PT3347009T (pt) 2015-07-08 2022-01-12 Triple Hair Inc Composição compreendendo resveratrol e melatonina para reduzir a perda de cabelo e/ou aumentar o crescimento do cabelo
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
MX2018001843A (es) * 2015-08-13 2018-05-16 River Town Therapeutics Inc Composiciones y metodos para tratar alopecia.
US10702544B2 (en) 2016-01-12 2020-07-07 National University Corporation Tokyo Medical And Dental University Composition for ameliorating loss of hair and graying of hair, and use thereof
US10946141B2 (en) * 2016-03-14 2021-03-16 Virchow Biotech Pvt. Ltd. Sterile protective cover comprising a device for opthalmic delivery
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017180822A1 (en) 2016-04-13 2017-10-19 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
WO2019005139A1 (en) * 2017-06-30 2019-01-03 Jenivision Inc. FORMULATIONS FOR HAIR GROWTH
IT201600070911A1 (it) * 2016-07-07 2018-01-07 Univ Degli Studi Di Torino Composizione comprendente chitosano per l'uso nella prevenzione e/o nel trattamento di incontinenza e/o impotenza in un soggetto sottoposto a prostatectomia
KR102017796B1 (ko) * 2016-07-28 2019-09-03 주식회사 큐어바이오 신규한 aimp1 단백질의 단편과 이를 유효성분으로 포함하는 발모 촉진용 조성물
WO2018030560A1 (ko) * 2016-08-11 2018-02-15 사회복지법인 삼성생명공익재단 디옥시콜산을 유효성분으로 포함하는 탈모의 예방, 개선 또는 치료용 조성물
EP3532025B1 (en) 2016-10-28 2021-02-24 Unilever N.V. Personal care compositions comprising surface-modified particles and non-volatile functionalised silicone
MX2019004869A (es) 2016-10-28 2019-08-12 Unilever Nv Una composicion para el cuidado personal que comprende particulas.
GB201622423D0 (en) * 2016-12-30 2017-02-15 Advanced Medical Solutions (Plymouth) Ltd Adhesive applicator
AU2018205253B2 (en) 2017-01-06 2022-01-13 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
KR101881417B1 (ko) * 2017-01-10 2018-07-26 주식회사 아미코스메틱 멘톨, 은행잎, 알로에, 녹차, 병풀 및 하수오 추출물을 포함하는 화장료 조성물
US9993578B1 (en) * 2017-01-12 2018-06-12 Lorstan Pharmaceutical, LLC Silicone oil-in-water composition useful as an injectable filler and as a scaffold for collagen growth
US20200390854A1 (en) * 2017-03-23 2020-12-17 The Regents Of The University Of California Stimulation of hair growth by senescent cells and senescence associated secretory phenotype
US11304953B2 (en) 2017-05-23 2022-04-19 Mei Pharma, Inc. Combination therapy
IL271443B2 (en) 2017-06-30 2024-01-01 Univ California Preparations and methods for regulating hair growth
MX2020001727A (es) 2017-08-14 2020-03-20 Mei Pharma Inc Terapia de combinacion.
WO2019055662A1 (en) * 2017-09-14 2019-03-21 Follica, Inc. METHODS FOR PROMOTING HAIR GROWTH USING VALPROIC ACID
CN115251850A (zh) * 2017-09-15 2022-11-01 株式会社玫丽盼 评价方法、毛发处理剂的选定方法以及评价辅助工具
AU2018339064A1 (en) * 2017-09-29 2020-02-27 The Regents Of The University Of California Compositions and methods for modulating hair growth
US11724941B2 (en) 2018-02-15 2023-08-15 North Carolina State University Synthesis of micron and nanoscale carbon spheres and structures using hydrothemal carbonization
WO2019200063A1 (en) * 2018-04-13 2019-10-17 North Carolina State University Use of microneedle patch to promote hair growth
US20220354764A1 (en) * 2018-05-30 2022-11-10 Follica, Inc. Methods for promoting hair growth
US11000513B2 (en) 2018-07-02 2021-05-11 Palvella Therapeutics, Inc. Anhydrous compositions of mTOR inhibitors and methods of use
CA3109184A1 (en) * 2018-08-14 2020-02-20 Mei Pharma, Inc. Treatment of b cell malignancies
AU2019329703B2 (en) * 2018-08-26 2022-12-15 Attain Health Inc. Methods and compositions to increase hair growth and/or prevent hair loss
CN109200482A (zh) * 2018-09-13 2019-01-15 厦门极乐岛科技有限公司 理疗仪及其理疗方法
JP2020069117A (ja) * 2018-10-31 2020-05-07 キヤノン株式会社 加工装置、制御方法及びプログラム
US11311529B2 (en) 2018-11-08 2022-04-26 Varsona Therapeutics, Inc. Topical formulations of 5-α-reductase inhibitors and uses thereof
WO2020096539A2 (en) * 2018-11-09 2020-05-14 Kahraman Yilmaz Hair transplantation technique that reduces the hair growth process and reaches a higher number of hair follicle
WO2020123842A1 (en) * 2018-12-12 2020-06-18 Drake Precision Optics, Inc. Ophthalmic surgery laser system and method for utilizing same for ophthalmic surgery
CN109528725B (zh) * 2019-01-15 2021-01-15 华中科技大学 一种含二氨基嘧啶氧化物和吡咯烷基二氨基嘧啶氧化物的纳米组合物及其制备方法与应用
US11260075B1 (en) * 2019-03-24 2022-03-01 Peter Friedman Non-thermal atmospheric plasma to treat hair loss
RU2713137C1 (ru) * 2019-05-29 2020-02-03 Валерий Викторович Педдер Устройство для магнито- и фотохромо-ультразвукового орошения биотканей лекарственными веществами
WO2021142291A1 (en) * 2020-01-10 2021-07-15 The General Hospital Corporation Stimulation of hair growth
USD907231S1 (en) * 2020-01-15 2021-01-05 Guangzhou Zhongshu E-Commerce Co., Ltd. Vibration massager
EP4090420A4 (en) * 2020-01-17 2024-01-24 Know Bio Llc PHOTOTHERAPEUTIC TREATMENT OF SKIN DISEASES
US20210308030A1 (en) * 2020-04-02 2021-10-07 Follea International System, methods and kits for diagnosis and treatment of female pattern hair loss
US11311556B2 (en) 2020-05-13 2022-04-26 Varsona Therapeutics, Inc. Topical dutasteride emulsions for treating endocrine therapy-induced alopecia
JP2022131579A (ja) 2021-02-26 2022-09-07 キオクシア株式会社 分析装置および分析方法
WO2023027993A1 (en) * 2021-08-23 2023-03-02 Veradermics Incorporated Compositions and methods for treatment of alopecia areata
FR3126302A1 (fr) 2021-09-01 2023-03-03 L'oreal OUTIL POUR LA PéNéTRATION DE COSMéTIQUES ANTICHUTE ET KIT UTILISANT CET OUTIL
USD1016615S1 (en) 2021-09-10 2024-03-05 Hydrafacial Llc Container for a skin treatment device
US20240000743A1 (en) * 2022-07-01 2024-01-04 Jjr&D, Llc Method of Preventing and Treating Chemotherapy-Induced Alopecia
CN115025237B (zh) * 2022-08-03 2023-08-18 山东理工大学 一种用于治疗脱发的米诺地尔超分子水凝胶及其制备方法
WO2024091572A1 (en) * 2022-10-25 2024-05-02 Veradermics Incorporated Compositions and methods of use for modified release minoxidil

Family Cites Families (197)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4139619A (en) * 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
FR2487677A1 (fr) 1980-08-04 1982-02-05 Commw Scient Ind Res Org Procede de depilation d'animaux
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US5183817A (en) * 1981-02-17 1993-02-02 Bazzano Gail S Combinations of retinoids and minoxidil-type compounds for hair growth
US4381778A (en) 1981-05-27 1983-05-03 George Kozam Needle-loading multiple barrel syringe
JPS60197613A (ja) * 1983-11-08 1985-10-07 Taki Asai 髪の精天然養毛液
HU196714B (en) 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
IE58110B1 (en) 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4689042A (en) 1985-05-20 1987-08-25 Survival Technology, Inc. Automatic medicament ingredient mixing and injecting apparatus
US5714482A (en) 1985-07-18 1998-02-03 Proctor; Peter H. Topical spin labels and method
GB8604360D0 (en) 1986-02-21 1986-03-26 Univ Dundee Stimulation of hair growth
DE3781034T2 (de) 1986-06-13 1993-02-18 Procter & Gamble Topische pharmazeutische zubereitung mit besserer durchdringungsfaehigkeit.
US5073543A (en) 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
US5612059A (en) 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP0569046B1 (en) 1988-09-06 2002-11-13 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
IT1229203B (it) 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
PH30995A (en) 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
EP0429842B1 (en) 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5120548A (en) 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5733566A (en) 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5122117A (en) 1990-06-05 1992-06-16 Habley Medical Technology Corp. Component mixing syringe
CA2052193A1 (en) 1990-09-28 1992-03-29 Norio Takasugi Topical powder composition containing cyclic amp derivative
GB9023701D0 (en) 1990-10-31 1990-12-12 Efamol Holdings Medical treatment
US5543390A (en) 1990-11-01 1996-08-06 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Covalent microparticle-drug conjugates for biological targeting
GB9026664D0 (en) 1990-12-07 1991-01-23 Unilever Plc Cosmetic composition
US5580578A (en) 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5423752A (en) 1992-07-31 1995-06-13 Habley Medical Technology Corporation Variable proportion dispenser with cartridge replacement assembly
US5972991A (en) 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US5688819A (en) 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
TW333456B (en) 1992-12-07 1998-06-11 Takeda Pharm Ind Co Ltd A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
US5591767A (en) 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
DE69332228T2 (de) 1993-02-09 2003-04-17 Tulsa Forte Pharmacy Entpr Inc Verfahren zur anregung des haarwachstums mit kationischen minoxidil-derivaten mittels therapeutischen iontophoresis
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5523092A (en) 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5985307A (en) 1993-04-14 1999-11-16 Emory University Device and method for non-occlusive localized drug delivery
US6087324A (en) 1993-06-24 2000-07-11 Takeda Chemical Industries, Ltd. Sustained-release preparation
US6004534A (en) 1993-07-23 1999-12-21 Massachusetts Institute Of Technology Targeted polymerized liposomes for improved drug delivery
JPH0748230A (ja) 1993-07-31 1995-02-21 Hideo Horiuchi 育毛剤の製造法
US5510383A (en) 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
IL107167A (en) 1993-10-03 2000-01-31 Raziel Lurie Compositions containing relaxin for treatment of alopecia and related conditions
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
IT1286624B1 (it) 1996-05-10 1998-07-15 Mattioli Eng Srl Apparecchiatura a componenti sterili monouso,per trattamenti di dermoabrasione mediante getti di sostanze riducenti
IT1270594B (it) 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5759542A (en) 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
US5660854A (en) 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
JPH10510175A (ja) 1994-12-09 1998-10-06 ノバルティス アクチェンゲゼルシャフト 経皮システム
US5631287A (en) 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6011062A (en) 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US5767152A (en) 1995-05-04 1998-06-16 Nielsen; Thor Bagger Composition and methods for stimulating hair growth
US6316652B1 (en) 1995-06-06 2001-11-13 Kosta Steliou Drug mitochondrial targeting agents
US5798119A (en) 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0835101B1 (en) 1995-06-27 2004-06-09 Takeda Chemical Industries, Ltd. Method of producing sustained-release preparation
TW448055B (en) 1995-09-04 2001-08-01 Takeda Chemical Industries Ltd Method of production of sustained-release preparation
JP2909418B2 (ja) 1995-09-18 1999-06-23 株式会社資生堂 薬物の遅延放出型マイクロスフイア
US6039975A (en) 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
US5980945A (en) 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
US5861432A (en) 1996-02-07 1999-01-19 Sklar; Jerald L. Glycolic acid and tretinoin formulation for the treatment of acne
TW345603B (en) 1996-05-29 1998-11-21 Gmundner Fertigteile Gmbh A noise control device for tracks
US6264970B1 (en) 1996-06-26 2001-07-24 Takeda Chemical Industries, Ltd. Sustained-release preparation
US6419961B1 (en) 1996-08-29 2002-07-16 Takeda Chemical Industries, Ltd. Sustained release microcapsules of a bioactive substance and a biodegradable polymer
US5983136A (en) 1996-09-17 1999-11-09 Deka Products Limited Partnership System for delivery of drugs by transport
US6375987B1 (en) 1996-10-01 2002-04-23 Gattefossé, S.A. Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix
EP1007012A4 (en) 1996-10-01 2006-01-18 Cima Labs Inc TASTE-MASKED MICRO-CAPSULE COMPOSITION AND MANUFACTURING PROCESS
CA2217134A1 (en) 1996-10-09 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Sustained release formulation
PT839525E (pt) 1996-10-31 2004-10-29 Takeda Chemical Industries Ltd Preparacao de libertacao prolongada
US6131570A (en) 1998-06-30 2000-10-17 Aradigm Corporation Temperature controlling device for aerosol drug delivery
DE19648576C2 (de) 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6197350B1 (en) 1996-12-20 2001-03-06 Takeda Chemical Industries, Ltd. Method of producing a sustained-release preparation
US6527716B1 (en) 1997-12-30 2003-03-04 Altea Technologies, Inc. Microporation of tissue for delivery of bioactive agents
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE69823852T2 (de) * 1997-02-04 2005-05-19 Johnstone, Murray A., Seattle Verfahren zur förderung des haarwuchses und entwicklung des haarsystems
IL131322A0 (en) 1997-02-12 2001-01-28 Johnson & Johnson Consumer Serine protease and topical retinoid compositions
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6060082A (en) 1997-04-18 2000-05-09 Massachusetts Institute Of Technology Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
US6187796B1 (en) * 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
US6409507B1 (en) * 1997-06-19 2002-06-25 Twist2It, Inc. Drive mechanism for oscillatory dental tool with improved bushing
AU8282998A (en) 1997-07-01 1999-01-25 Jerry E. Cooley Method for producing new hair growth
WO1999003521A1 (en) 1997-07-14 1999-01-28 Novo Nordisk A/S Injection member
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
US5957895A (en) 1998-02-20 1999-09-28 Becton Dickinson And Company Low-profile automatic injection device with self-emptying reservoir
US6613358B2 (en) 1998-03-18 2003-09-02 Theodore W. Randolph Sustained-release composition including amorphous polymer
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
US6048736A (en) 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
KR19990085365A (ko) 1998-05-16 1999-12-06 허영섭 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법
US7169410B1 (en) 1998-05-19 2007-01-30 Sdg, Inc. Targeted liposomal drug delivery system
US6159950A (en) 1998-10-16 2000-12-12 Cornell Research Foundation, Inc. Method of modulating hair growth
IL142896A0 (en) 1998-11-02 2002-04-21 Elan Corp Plc Multiparticulate modified release composition
AU1917000A (en) 1998-11-20 2000-06-13 Arch Development Corporation Regulation of hair follicle morphogenesis based on beta-catenin
US6936044B2 (en) 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US6726693B2 (en) 2000-11-10 2004-04-27 Pearl Technology Holdings, Llc Tissue resurfacing using biocompatible materials
US6306119B1 (en) 1999-01-20 2001-10-23 Pearl Technology Holdings, Llc Skin resurfacing and treatment using biocompatible materials
WO2000045736A1 (en) 1999-02-08 2000-08-10 Bioamide, Inc. Filamentary means for introducing agents into cells
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6271359B1 (en) 1999-04-14 2001-08-07 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
WO2000067692A1 (en) * 1999-05-11 2000-11-16 Dynatronics Corporation Method and system for performing microabrasion and massage
US6458387B1 (en) 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
GB9925964D0 (en) 1999-11-03 1999-12-29 Jahoda Colin A B Hair transplantation
DE10005329A1 (de) 2000-02-08 2001-09-20 Albert Scheller Humanisiertes, vitalisiertes Haarbewachsen und Haarwiederbewachsen mit subkutanen Kanüleneinstich-Haut-Färbungs-Zeichnungsverfahren
US6416769B1 (en) 2000-03-03 2002-07-09 Australian Importers, Ltd. Cosmetic compositions comprising exfoliating enzymes and uses thereof
US7115653B2 (en) 2000-03-30 2006-10-03 Curis, Inc. Small organic molecule regulators of cell proliferation
JP4813734B2 (ja) 2000-03-31 2011-11-09 ザ ジェネラル ホスピタル コーポレイション 毛の成長を調節する方法
EP1186287A1 (en) 2000-03-31 2002-03-13 Toray Industries, Inc. Hair growth or hair formation controlling agents
GB0008494D0 (en) 2000-04-07 2000-05-24 Secr Defence Microprojectile delivery system
US6623756B1 (en) 2000-04-27 2003-09-23 Noveon Ip Holdings Corp. Directly compressed solid dosage articles
JP2001314518A (ja) * 2000-05-10 2001-11-13 Advance Co Ltd 角質層処理器具及びイオントフォレーゼ用デバイス
US20040185127A1 (en) 2001-06-29 2004-09-23 Lerner David S. Cosmetic composition and method
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US20060286063A1 (en) 2000-11-06 2006-12-21 Afmedica, Inc. Combination drug therapy for reducing scar tissue formation
DE10061162A1 (de) 2000-11-30 2002-07-11 Schering Ag Aryl-substituierte Indirubinderivate, deren Herstellung und Verwendung
EP1367982A2 (en) 2001-01-29 2003-12-10 Aderans Research Institute, Inc. Hair follicle neogenesis by injection of follicle progenitor cells
DK2163256T3 (en) 2001-05-11 2015-12-07 Ludwig Inst For Cancer Res Ltd Specific binding proteins and use thereof
ES2254611T3 (es) 2001-05-11 2006-06-16 Pfizer Products Inc. Derivados de tiazol.
ES2267945T3 (es) 2001-05-31 2007-03-16 Pfizer Products Inc. Uso medico de compuestos tiromimeticos para tratar la perdida del cabello y composiciones.
RU2245136C2 (ru) 2001-07-27 2005-01-27 Яманоути Фармасьютикал Ко., ЛТД Композиция, включающая тонкодисперсные частицы с замедленным высвобождением для быстроразлагающихся в щечной полости таблеток, и способ ее получения
JP2003081866A (ja) 2001-09-13 2003-03-19 Yasuhiko Tabata 細胞成長因子蛋白質を含む育毛用ハイドロゲル
EP1429746B1 (en) 2001-09-28 2008-08-13 McNEIL-PPC, INC. Dosage forms having an inner core and outer shell
US6831186B2 (en) 2001-11-06 2004-12-14 Schering Aktiengesellschft Lipoxin A4 analogs
ATE287259T1 (de) 2001-12-19 2005-02-15 Astrazeneca Ab Neue filmbeschichtung enthaltend ein äthylacrylate/methylmethacrylate-copolymer und polyvinylacetat
JP2003192541A (ja) 2001-12-26 2003-07-09 Pola Chem Ind Inc 育毛促進剤及び育毛用の皮膚外用剤
US7105489B2 (en) 2002-01-22 2006-09-12 Amylin Pharmaceuticals, Inc. Methods and compositions for treating polycystic ovary syndrome
US20030161815A1 (en) 2002-02-12 2003-08-28 Intercytex Limited Cell delivery system
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
DE10224982A1 (de) 2002-06-05 2003-12-24 Rolf Hoffmann Mesenchymale Stammzellen des Haarfollikels und deren Verwendung
US20040087972A1 (en) * 2002-09-16 2004-05-06 Mulholland Robert Stephen Skin abrading apparatus
US20040236269A1 (en) 2002-09-25 2004-11-25 Marchitto Kevin S. Microsurgical tissue treatment system
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20040142853A1 (en) 2002-11-07 2004-07-22 Procyte Corporation Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil
MXPA05006485A (es) 2002-12-17 2005-08-26 Schering Corp Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades dependientes de androgeno.
US7485322B2 (en) 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
US20040153131A1 (en) 2003-02-04 2004-08-05 Yorke John A. Apparatus and method for hair retention and regeneration
US20050031571A1 (en) 2003-05-16 2005-02-10 Khaiat Alain V. Topical treatment of ingrown hairs
US7271188B2 (en) 2003-06-12 2007-09-18 Chugai Seikayu Kabushiki Kaisha Imidazolidine derivatives
CN103880955A (zh) 2003-07-18 2014-06-25 安姆根有限公司 肝细胞生长因子的特异性结合物
US20060018966A1 (en) 2003-07-22 2006-01-26 Lin Victor S Antimicrobial mesoporous silica nanoparticles
US20050054663A1 (en) 2003-08-13 2005-03-10 Bennett Christina N. GSK-3 inhibitors
US7179477B2 (en) 2003-08-15 2007-02-20 Shyam K Gupta Cosmetic dermabrasion treatment system
EP1660172A1 (en) 2003-08-26 2006-05-31 Alza Corporation Device and method for intradermal cell implantation
WO2005020940A1 (de) 2003-08-27 2005-03-10 Beiersdorf Ag Kapsel deren kapselhülle bei topischer anwendung nicht mehr gesondert warhnembar ist
US20070190075A1 (en) 2003-10-09 2007-08-16 Advangen, Inc. C/O National Institute Of Advance Science And Tech Hair growth stimulant composition
US20070207228A1 (en) 2004-03-02 2007-09-06 Giammaria Giuliani Composition for Regulating the Trophism of Hair Follicles and the Cutaneous Production of Sebum and Use Thereof in Androgenic Alopecia
US20060063736A1 (en) 2004-03-25 2006-03-23 Bertozzi Carolyn R Compositions and methods for inhibiting mucin-type O-linked glycosylation
EP1586318A1 (en) 2004-04-05 2005-10-19 Neuropharma S.A.U. Thiadiazolidinones as GSK-3 inhibitors
CA2565236A1 (en) 2004-05-06 2005-11-17 Ivrea Pharmaceuticals, Inc. Particles for the delivery of active agents
CN1953717A (zh) 2004-05-19 2007-04-25 傲士屯有限公司 治疗脱发用的低功率激光照射器
ATE451950T1 (de) 2004-06-14 2010-01-15 Unilever Nv Verfahren zur verminderung der talgproduktion und porengrösse
JP2008505680A (ja) 2004-07-08 2008-02-28 オールトレイセル・ディベロップメント・サービシズ・リミテッド 皮膚の創傷の出血を制御するための送達システム
US7384405B2 (en) * 2004-09-10 2008-06-10 Rhoades Dean L Oxygenating cosmetic instrument having various numbers of heads
US20060058238A1 (en) 2004-09-15 2006-03-16 Lee Laurent-Applegate Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same
PT1796660T (pt) 2004-09-17 2017-02-13 Biomas Ltd Utilização de tricloro(dioxietileno-o,o¿)telurato de amónio (as101) para a inibição da enzima de conversão da interleucina-1 beta
ES2747926T3 (es) 2004-09-27 2020-03-12 Special Water Patents B V Métodos y composiciones para el tratamiento de agua
US7910755B2 (en) 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses
US20060073117A1 (en) 2004-10-01 2006-04-06 Stowers Institute For Medical Research Methods and compositions for controlling hair follicle stem cell fate
WO2006050368A2 (en) 2004-11-01 2006-05-11 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use
AU2006230187B2 (en) 2005-03-29 2012-07-26 The Trustees Of The University Of Pennsylvania Methods for generating new hair follicles, treating baldness, and hair removal
US20060241696A1 (en) 2005-04-26 2006-10-26 Stjepan Krco Method of limiting hair loss and promoting hair growth
US20060269494A1 (en) 2005-05-27 2006-11-30 Gupta Shyam K New Ubiquitin-Proteasome Regulating Compounds and Their Application in Cosmetic and Pharmaceutical Formulations
US7517852B2 (en) 2005-07-28 2009-04-14 Biosynexus Incorporated Compositions and methods for treating bacteria
US20070078290A1 (en) 2005-09-30 2007-04-05 Esenaliev Rinat O Ultrasound-based treatment methods for therapeutic treatment of skin and subcutaneous tissues
EP1945757B1 (en) 2005-10-17 2017-12-06 Aderans Research Institute, Inc. Method of delivering hair follicle progenitor cells to the skin
US20070129353A1 (en) 2005-11-08 2007-06-07 Michael Kahn Alpha-helix mimetics and method relating to the treatment of cancer stem cells
US20070243132A1 (en) 2005-12-22 2007-10-18 Apollo Life Sciences Limited Transdermal delivery of pharmaceutical agents
US20070249714A1 (en) 2005-12-30 2007-10-25 Judy Hattendorf Method of treating skin requiring fractional resurfacing treatment
US7427414B2 (en) 2006-01-18 2008-09-23 Astron Research Limited Modified release oral dosage form using co-polymer of polyvinyl acetate
US20150072963A1 (en) 2006-06-16 2015-03-12 The Trustees Of The University Of Pennsylvania Compositions and methods for regulating hair growth
DK2037967T3 (en) 2006-06-16 2017-03-13 Univ Pennsylvania PROSTAGLANDIN-D2 RECEPTOR ANTAGONISTS FOR TREATMENT OF ANDROGENETIC ALOPECI
BRPI0719509A2 (pt) 2006-09-28 2013-12-31 Follica Inc Métodos, kits e composições para geração de novos folículos pilosos e crescimento de cabelos
US8273747B2 (en) 2006-11-02 2012-09-25 Curis, Inc. Small organic molecule regulators of cell proliferation
US20080182859A1 (en) 2006-11-02 2008-07-31 Curis, Inc. Small organic molecule regulators of cell proliferation
EP2139444A2 (en) 2007-03-21 2010-01-06 Dow Global Technologies Inc. Sustained-release composition
SI2152358T1 (sl) * 2007-04-27 2011-08-31 Echo Therapeutics Inc Naprava za prodiranje skozi koĺ˝o za analizno merjenje ali za transdermalni prenos zdravil
CA2684604A1 (en) 2007-05-15 2008-11-27 Puretech Ventures Methods and compositions for treating skin conditions
US9511040B2 (en) 2007-06-20 2016-12-06 The Trustees Of Columbia University In The City Of New York Skin and surface disinfectant compositions containing botanicals
JP2010540425A (ja) 2007-09-21 2010-12-24 インターサイテックス リミテッド 毛包形成を増強するための表皮刺激
JP2011502571A (ja) 2007-11-05 2011-01-27 ピュアテック ベンチャーズ 医薬化合物を投与するための方法、キット、および組成物
WO2009072711A2 (en) * 2007-12-07 2009-06-11 Myeong In Lee Disk needle roller
US8871711B2 (en) 2008-11-12 2014-10-28 The Trustees Of The University Of Pennsylvania Fibroblast growth factor-9 promotes hair follicle regeneration after wounding
KR20120113211A (ko) * 2009-09-11 2012-10-12 폴리카 인코포레이티드 모발 성장을 조절하기 위한 간헐 리튬 치료 및 펄스 리튬 치료
WO2011031977A1 (en) 2009-09-11 2011-03-17 Follica, Inc. Intermittent and pulse lithium treatments for scar revision and wound healing
US20110130706A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Sequential body surface treatment
US20110130711A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
US20110130748A1 (en) 2009-11-19 2011-06-02 Follica, Inc. Body surface treatment
AU2011233613A1 (en) 2010-03-29 2012-10-18 Follica, Inc. Combination therapy
TWI422385B (zh) * 2010-10-06 2014-01-11 Central Medical Technologies Inc Hair growth agent containing platelet dry powder
WO2012065065A1 (en) * 2010-11-12 2012-05-18 Follica, Inc. Methods and compositions for modulating hair growth, wound healing and scar revision
JP2014500275A (ja) * 2010-12-06 2014-01-09 フォリカ，インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
WO2012125941A1 (en) 2011-03-17 2012-09-20 Follica, Inc. Lithium treatment for microbial infections
JP6193968B2 (ja) 2012-03-21 2017-09-06 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア 発毛を調節するための組成物および方法

Also Published As

Publication number Publication date
IL254431A0 (en) 2017-11-30
AU2017203471A1 (en) 2017-06-08
EP2648676A4 (en) 2016-05-04
WO2012078649A1 (en) 2012-06-14
AU2018226435A1 (en) 2018-09-27
AU2011338530A1 (en) 2013-07-04
US20140079686A1 (en) 2014-03-20
US11207511B2 (en) 2021-12-28
EP2648676A1 (en) 2013-10-16
BR112013014021A2 (pt) 2016-07-12
JP2021121621A (ja) 2021-08-26
AU2011338530B2 (en) 2017-06-15
JP2019131558A (ja) 2019-08-08
JP2014500275A (ja) 2014-01-09
US20190381296A1 (en) 2019-12-19
US20220193383A1 (en) 2022-06-23
IL226699A (en) 2017-10-31
CA2819859A1 (en) 2012-06-14
JP2017081962A (ja) 2017-05-18
EP3178465A1 (en) 2017-06-14

Similar Documents

Publication Publication Date Title
BR112013014021A8 (pt) Métodos para tratamento de calvície e promoção de crescimento de cabelos
BRPI0816214B8 (pt) uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
PH12016502254A1 (en) Keratin treatment formulations and methods
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
BR112018005110A2 (pt) Composição emoliente e sua utilização cosmética, composição cosmética, dermatológica ou farmacêutica e sua utilização cosmética e processo de tratamento cosmético da pele
BRPI0810336A2 (pt) "método para tratar e/ou prevenir úlceras de pele em um indivíduo"
BR112013017506A2 (pt) dispositivos e métodos de tratamento de feridas e da pele
BR112016022455A2 (pt) Uso de um sobrenadante de culturas de uma cepa de espécies de bacillus pumilus, composição cosmética ou dermofarmacêutica não natural, e, método não terapêutico para aumentar os níveis de adiponectina, aumentar a atividade mitocondrial no músculo, aumentar a resistência muscular e/ou repitelização da pele, estimular a síntese de colágeno e/ou a síntese de ácido hialurônico, tratamento de endurecimento da pele e/ou prevenção da perda de firmeza da pele
BRPI0916564A2 (pt) aparelho de uso pessoal para o tratamento seguro da pele e método de uso
BR112014006455A2 (pt) alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis
BR112017016759A2 (pt) recipiente de plástico pré-carregado, kit, uso do recipiente de plástico pré-carregado, método para o tratamento de uma doença ou condição, método para o tratamento cosmético da pele
BRPI0919316A2 (pt) sistema comestico ou dermatologico, e, metodo para tratar cosmeticamente pele ou cabelo
BR112014000318A2 (pt) composição, uso cosmético não terapêutico e método não terapêutico de cuidado com a pele e/ou de maquiagem
AR097599A1 (es) Una composición que comprende extracto de guaçatonga y aroeira, su uso y un método para la prevención y/o tratamiento de señales causadas por el envejecimiento de la piel
BR112021016296A2 (pt) Formulações tópicas de rapamicina e seu uso em tratamento de angiofibromas faciais e outros distúrbios de pele
BR112012026875A2 (pt) uso de eclipta prostrata e outros inibidores ppar-gamma em cosméticos e suas composições.
WO2011121250A3 (fr) Composition cosmetique et pharmaceutique comprenant de la n-acetyl-glucosamine- 6 - phosphate
BR112014019440A8 (pt) Composição para aplicação tópica, método para tratamento cosmético e uso de uma composição cosmética
BRPI0811273A2 (pt) Composição anti-envelhecimento para cuidado da pele, e, método de tratamento cosmético da pele
BR112014002595A2 (pt) uso de esfinganina para melhorar a aparência visual da pele e cabelo
BR112012024630B8 (pt) Processos para o tratamento cosmético de envelhecimento da pele
BR112018071492A2 (pt) extratos de saxifraga para uso cosmético e terapêutico na pele
BR112015029815A2 (pt) composição cosmética para clarear uma pele e/ou cabelo de um indivíduo, conjunto para clarear uma pele e/ou um cabelo de um individuo, método cosmético para clarear uma pele e/ou um cabelo de um individuo, composição cosmética ou farmacêutica para aplicação na pele, cabelo e/ou unha de um indivíduo, conjunto para aplicar uma composição cosmética ou farmacêutica na pele cabelo e/ou unha de um individuo e método de administração de peróxido de hidrogênio na pele, cabelo e/ou unha de indivíduo.
WO2013190567A3 (en) Composition and method for an intradermal hair growth solution
MX2021010546A (es) Composiciones y metodos para tratamiento de la piel.

Legal Events

Date Code Title Description
B15I Others concerning applications: loss of priority

Free format text: PERDA DAS PRIORIDADES US61/420,282 DE 06/12/2010, US61/478,689 DE 25/04/2011, US61/453,919 DE 17/03/2011, US61/453,902 DE 17/03/2011 E US61/513,906 DE 01/08/2011 REIVINDICADAS NO PCT/US2011/063557, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O, ITEM 28 DO ATO NORMATIVO 128/97 E NO ART. 29 DA RESOLUCAO INPI-PR 77/2013. ESTA PERDA SE DEU PELO FATO DE O DEPOSITANTE CONSTANTE DA PETICAO DE REQUERIMENTO DO PEDIDO PCT (FOLLICA, INC. ) SER DISTINTO DAQUELE QUE DEPOSITOU A PRIORIDADE REIVINDICADA E NAO APRESENTOU DOCUMENTO COMPROBATORIO DE CESSAO, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 6O, ITEM 27 DO ATO NORMATIVO 128/97 E NO AR

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/49 (2006.01), A61K 8/42 (2006.01), A61K 8/4

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.